India’s drug regulator to streamline export process to reduce workload
By Rishika Sadam MUMBAI (Reuters) – India’s drug regulator aims to implement various reforms, including streamlining export clearances for unapproved drugs and simplifying the manufacturing licensing process, in an effort to reduce the burden on its workforce, its head said on Thursday. The agency has only 2,000 officials to oversee over 10,000 drug factories and …
India’s drug regulator to streamline export process to reduce workload Read More »









